Sign in
WithdrawnNo phase

Technology Knowledge Optimization in Type 1 Diabetes (TeKnO T1D): Parents

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Philadelphia, United StatesSee the site
Trial code
Status
Withdrawn
Started
15 Aug 2025
Expected to end
31 Jul 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • TeKnO T1D: Parents
Record updated
9 October 2025
Why it stopped
Investigator left the institution and is relinquishing the award supporting this study. The study will not launch.

Who can take part

Age
8 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • child 8-12 years of age with a diagnosis of T1D ≥ 6 months
  • currently using insulin pump( IP) and CGM ≥ 1 month [including Hybrid Closed Loop (HCL) systems]
  • participation of primary diabetes caregiver
  • English fluency
  • mean A1c >7.5% over the past 6 months (Aim 3 only)

Who cannot take part

  • major illnesses other than T1D in the child
  • significant cognitive limitations or major psychiatric disorders in the child or parent
  • the use of medications other than insulin to control blood glucose levels

Where in United States

  • Childrens Hospital of PhiladelphiaPhiladelphia, United States

About the trial

What the trial wants to find out

This study aims to identify the unmet psychoeducational needs of parents of children 8-12 years of age using insulin pump and CGM for pediatric T1D management and to leverage that information to develop an innovative app-based psychoeducational intervention to optimize use of these technologies and improve T1D outcomes.

The 3 groups in the trial

  • Arm 1: Semi-structured InterviewsNo study treatment, for comparison

    Arm 1 will be conducted from months 0-15 and will use interviews to better understand existing challenges in diabetes technology educational practices. It is not a clinical trial, but is a crucial part of what builds to the clinical trial.

  • Arm 2: Designing an App Delivered CurriculumTreatment being tested

    Arm 2 will be conducted from months 10-33 and will use information learned in arm 1 to develop and beta test an educational curriculum. Arm 2 also is not a clinical trial, but is a crucial part of what builds to the clinical trial.

    Treatment: TeKnO T1D: Parents

  • Arm 3: TeKnO T1D: Parents Pilot StudyExisting treatment, for comparison

    Arm 3 will be conducted from months 30-60 and involves a pilot and feasibility study of the newly developed educational curriculum. This is the clinical trial.

    Treatment: TeKnO T1D: Parents

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
9 October 2025